Jump to content
data17

Articles on UK Drug shortages from December 2017

Recommended Posts

data17

These articles have appeared in The Times in December 2017  - you need to register to read the full articles.

 

https://www.thetimes.co.uk/article/drug-shortages-cost-nhs-38m-as-patients-struggle-xjvmjkwqj

Medicine shortages cost the NHS another £38 million last month, as officials say they are largely powerless to solve a problem that leaves patients struggling to obtain essential drugs.

Monday December 18 2017  |  The Times

 

https://www.thetimes.co.uk/article/nhs-close-to-blowing-entire-winter-fund-on-costly-drugs-pvmgr9mwn

Ministers are under pressure to protect patients and the NHS budget by getting to the root of worsening medicine shortages that have led to cancer and mental health patients going without crucial drugs. Medicine wholesalers have been summoned to the Department of Health to explain their handling of the crisis. They denied that they had been manipulating the market.

Friday December 8 2017  |  The Times

 

https://www.thetimes.co.uk/article/patients-hit-by-shortage-of-drugs-as-prices-soar-tv2ps2p66

Ministers are facing mounting demands to ensure the NHS is not “taken for a ride” over drugs shortages which have cost £180 million in six months.

Thursday December 7 2017  |  The Times

 

Here is commentary by EBM Datalab at University of Oxford.

 

https://ebmdatalab.net/drug-shortages-and-price-concessions-how-much-is-it-costing-the-nhs/

 

"There has been an interesting and concerning story in The Times today regarding shortages on a number of commonly-used medicines and a corresponding increase in the costs.

Here at OpenPrescribing we have been taking a look at these data as well, and trying to estimate to the cost to the NHS this year.

As the Times article suggested, the excess costs are now hitting £50m per month, with £175m extra spent in primary care by September:"

 

"Why has it happened?

It’s not clear.  There have been various reasons discussed, including Brexit, stock shortages, and suggestions that wholesalers have been holding back stock.  What’s certain is that the partial removal of manufacturing authorisations from Bristol Laboratories and Dr Reddy’s manufacturing plants hasn’t helped.

What happens when drugs are no longer in short supply?

Often when a price concession no longer applies the price returns to what it was before the shortage.  But increasingly this is not the case, and the “Drug Tariff” price increases to near the “price concession” value.  For example, olanzapine 10mg tablets, an anti-psychotic, which has increased from £1.09 to £21.95 a pack.  If this price stays the same, the NHS will spend about £27 million per year on all generic olanzapine tablets, compared with about £2m last year."

 

 

 

Share this post


Link to post
Share on other sites
nz11
2 hours ago, data17 said:

For example, olanzapine 10mg tablets, an anti-psychotic, which has increased from £1.09 to £21.95 a pack.  If this price stays the same, the NHS will spend about £27 million per year on all generic olanzapine tablets, compared with about £2m last year."

This is just outrageous!!

Pharma sure have been given the license to kill and steal. 

 

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now

×

Important Information

By using this site, you agree to our Terms of Use.